Patient Management

2074 soru

Soru 1541Soru →

A 58-year-old man is preparing for discharge from the cardiac intensive care unit. He was admitted 4 days ago for ventricular tachycardia storm, experiencing multiple recurrent implantable cardioverter-defibrillator (ICD) shocks. He was stabilized on an intravenous amiodarone infusion and is now being transitioned to an oral amiodarone loading regimen (400 mg three times daily) to suppress further arrhythmias.

His past medical history is significant for ischemic cardiomyopathy with a left ventricular ejection fraction of 20%, permanent atrial fibrillation, mechanical mitral valve replacement 5 years ago, and stable chronic kidney disease.

His home medications, which were continued throughout his hospitalization, include warfarin 5 mg daily, digoxin 0.125 mg daily, metoprolol succinate 100 mg daily, lisinopril 20 mg daily, and furosemide 40 mg daily.

Today's laboratory results are as follows:

Laboratory TestResultReference / Target
Serum creatinine1.7 mg/dLBaseline 1.6 mg/dL
Serum potassium4.2 mEq/L3.5 - 5.0 mEq/L
INR3.12.5 - 3.5
Serum digoxin0.8 ng/mL0.5 - 0.9 ng/mL

Which of the following is the most appropriate next step in treatment adaptation and monitoring for this patient at discharge?

Cevabı ve açıklamayı göster

Cevap: Reduce both the warfarin and digoxin doses by 30% to 50%, and schedule a follow-up for INR and serum digoxin level checks in 3 to 7 days.

Cevap

Reduce both the warfarin and digoxin doses by 30% to 50%, and schedule a follow-up for INR and serum digoxin level checks in 3 to 7 days.
The correct approach recognizes the potent and predictable pharmacokinetic interactions introduced by amiodarone. Amiodarone strongly inhibits CYP2C9, the primary enzyme responsible for metabolizing the highly active S-enantiomer of warfarin. Concurrently, it inhibits P-glycoprotein, a critical drug efflux pump responsible for the clearance of digoxin. Without preemptive intervention, the amiodarone loading regimen will cause a rapid and dangerous rise in both INR (leading to hemorrhage) and serum digoxin (leading to further ventricular arrhythmias). The standard of care mandates empirical dose reductions of 30% to 50% for both medications upon amiodarone initiation, followed by close laboratory surveillance within 3 to 7 days.

Adım Adım Çözüm

1
Identify the critical active medications and the newly added agent.
The patient is on warfarin and digoxin (narrow therapeutic index drugs) and is starting a high-dose amiodarone loading regimen.
Establishing the medication profile is essential for predicting drug-drug interactions.
2
Determine the pharmacokinetic effects of amiodarone on the patient's existing regimen.
Amiodarone inhibits CYP2C9, significantly decreasing warfarin metabolism. It simultaneously inhibits P-glycoprotein, significantly decreasing the renal clearance of digoxin.
Understanding the specific enzymatic pathways affected by amiodarone predicts the trajectory of concomitant drug levels.
3
Formulate a proactive management plan to prevent toxicity.
Empirical reductions of 30% to 50% for both warfarin and digoxin are required, alongside close laboratory monitoring within the first week.
Preemptive dose adjustment prevents bleeding complications and digoxin toxicity (which can trigger further arrhythmias), ensuring safe transitions of care.

Anahtar Kavram

Initiation of amiodarone requires empirical dose reductions (typically 30-50%) of both warfarin (due to CYP2C9 inhibition) and digoxin (due to P-glycoprotein inhibition) to prevent severe toxicity.
Soru 1542Soru →

A 65-year-old woman comes to the ambulatory clinic for a routine health maintenance examination. She has no acute complaints. Her medical history is notable for mild, intermittent lower back pain that is well-controlled with occasional over-the-counter ibuprofen. She went through menopause at age 52. She has never smoked, consumes alcohol occasionally, and walks 30 minutes daily. Vital signs are within normal limits. Physical examination, including a musculoskeletal assessment, shows no abnormalities. Which of the following is the most appropriate next step in management for this patient?

Cevabı ve açıklamayı göster

Cevap: Ordering dual-energy x-ray absorptiometry

Cevap

Ordering dual-energy x-ray absorptiometry
The correct answer is ordering dual-energy x-ray absorptiometry. The United States Preventive Services Task Force (USPSTF) recommends screening for osteoporosis with bone measurement testing (such as a DEXA scan) to prevent osteoporotic fractures in all women aged 65 years and older. This patient has reached the age threshold and requires this newly indicated screening.

Adım Adım Çözüm

1
Identify the patient's demographic and risk factors
The patient is a 65-year-old female with no history of smoking and no acute or red-flag symptoms.
Age, sex, and smoking history are primary determinants for identifying appropriate preventive screening guidelines.
2
Determine the age-appropriate screening guidelines for this demographic
The USPSTF recommends bone measurement testing to prevent osteoporotic fractures in women aged 65 years and older.
This is a Grade B recommendation intended to identify osteoporosis early and initiate treatment to prevent future fractures.
3
Rule out non-indicated interventions
Abdominal aortic aneurysm and lung cancer screenings are incorrect due to a lack of smoking history and specific sex criteria. Lumbar MRI and systemic estrogen are clinically inappropriate.
Avoiding unnecessary diagnostic tests and harmful treatments is a key component of effective preventive care.

Anahtar Kavram

The United States Preventive Services Task Force (USPSTF) recommends screening for osteoporosis with bone measurement testing (e.g., DEXA scan) in all women aged 65 years and older.
Soru 1543Soru →

A 54-year-old man presents to the clinic for a routine health maintenance visit. His past medical history is significant for type 2 diabetes mellitus, well-controlled on metformin, and primary hypertension treated with lisinopril. He has a 25-pack-year smoking history but successfully quit smoking 2 years ago. He drinks alcohol socially and denies illicit drug use.

His last primary care visit was 5 years ago, during which he received a tetanus, diphtheria, and acellular pertussis (Tdap) booster. He receives an annual influenza vaccine at his local pharmacy. At age 51, he completed a two-dose series of the recombinant zoster vaccine. He has no history of pneumococcal vaccination.

A screening colonoscopy performed at age 46 revealed two diminutive hyperplastic polyps in the distal rectum, which were completely excised. He had a one-time screening test for Hepatitis C and HIV at age 48, both of which were negative.

His vital signs today are temperature 37.0∘C37.0^\circ\text{C} (98.6∘F98.6^\circ\text{F}), blood pressure 128/78 mmHg128/78\text{ mmHg}, heart rate 72/min72/\text{min}, and respiratory rate 14/min14/\text{min}. BMI is 31 kg/m231\text{ kg/m}^2. Physical examination is unremarkable.

Which of the following interventions are indicated for this patient during today's visit? (Select all that apply)

Geçerli olan tümünü seçin

Cevabı ve açıklamayı göster

Cevap: Low-dose computed tomography (LDCT) of the chest; Pneumococcal conjugate vaccination

Cevap

The indicated interventions for this patient are low-dose computed tomography (LDCT) of the chest and pneumococcal conjugate vaccination.
The interventions that are indicated for this patient today are lung cancer screening with LDCT and pneumococcal conjugate vaccination. The USPSTF recommends annual LDCT screening for adults aged 50 to 80 years who have a ≥20\geq 20 pack-year smoking history and currently smoke or have quit within the past 15 years. This 54-year-old patient fulfills these criteria. Furthermore, the CDC recommends pneumococcal vaccination (e.g., PCV20) for adults aged 19 to 64 years who have underlying medical conditions that increase the risk of invasive pneumococcal disease. This patient's type 2 diabetes mellitus and history of cigarette smoking are both qualifying indications.

Adım Adım Çözüm

1
Evaluate the patient's eligibility for lung cancer screening.
The patient is 54 years old with a 25-pack-year smoking history and quit 2 years ago. This meets the criteria for annual LDCT screening.
USPSTF guidelines require annual LDCT for adults aged 50 to 80 with at least a 20-pack-year history who currently smoke or have quit within 15 years.
2
Assess the patient's immunization needs, particularly for pneumococcal disease.
The patient has type 2 diabetes mellitus and a smoking history, making him eligible for pneumococcal vaccination prior to age 65.
Adults aged 19 to 64 with high-risk comorbidities (e.g., diabetes, chronic heart/lung/liver disease, smoking, alcoholism) require pneumococcal vaccination.
3
Determine the appropriate interval for the patient's next surveillance colonoscopy.
The previous colonoscopy showed only distal hyperplastic polyps, which means the screening interval remains 10 years.
Diminutive (<10 mm<10\text{ mm}) hyperplastic polyps in the rectum or sigmoid colon are considered non-neoplastic and do not warrant a shortened surveillance interval.
4
Review other age- and risk-based screening guidelines for AAA and tetanus boosters.
Neither AAA screening nor a Td/Tdap booster is indicated at this time.
AAA screening is recommended for men starting at age 65 who have ever smoked. A Td/Tdap booster is required every 10 years, and his last dose was 5 years ago.

Anahtar Kavram

Application of age- and risk-based preventive screening and immunization guidelines in the primary care setting.
Soru 1544Soru →

A hospital system's medical director is reviewing disposition and care transition protocols to ensure compliance with federal guidelines. To optimize resource utilization and prevent unsafe discharges, physicians must accurately match patients to post-acute care settings based on regulatory criteria. Arrange the following care settings in descending order of their mandated medical intensity, starting from the HIGHEST level of required physician oversight and complex medical care down to the LOWEST level.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct descending order of medical intensity is Long-Term Acute Care Hospital (LTACH), followed by Inpatient Rehabilitation Facility (IRF), then Skilled Nursing Facility (SNF), and finally Custodial Care Facility.
The appropriate triage of patients to post-acute care settings depends heavily on the intensity of physician oversight and skilled nursing required by the patient. Long-Term Acute Care Hospitals (LTACHs) manage the most critically ill patients who no longer need the ICU but still require daily physician intervention. Inpatient Rehabilitation Facilities (IRFs) require intense therapy and physician visits at least 3 times a week. Skilled Nursing Facilities (SNFs) provide daily skilled care but mandate physician visits only every 30 days initially. Custodial care provides non-medical assistance with daily activities and has the lowest regulatory requirement for physician involvement.

Adım Adım Çözüm

1
Identify the setting with the highest medical acuity and physician oversight.
Long-Term Acute Care Hospital (LTACH) is placed first.
LTACHs function as extended intensive care units for medically complex patients, requiring daily physician evaluation and intervention.
2
Compare the remaining post-acute skilled settings to determine the next highest intensity.
Inpatient Rehabilitation Facility (IRF) is placed second.
IRFs require intensive therapy and close medical supervision with mandatory physician visits at least 3 times a week, which is a higher regulatory requirement than SNFs.
3
Evaluate the remaining options for skilled versus non-skilled care.
Skilled Nursing Facility (SNF) is placed third.
SNFs provide necessary daily skilled nursing or therapy but only require physician visits every 30 days initially, making it lower intensity than an IRF but higher than custodial care.
4
Identify the setting with the lowest regulatory requirement for physician oversight.
Custodial Care Facility is placed last.
Custodial facilities assist primarily with activities of daily living and do not provide ongoing skilled medical or nursing care.

Anahtar Kavram

Regulatory requirements and medical intensity levels of post-acute care settings
Tahmini Süre:1m 15s
Soru 1545Soru →

A 29-year-old woman is admitted to the medical ward for an acute flare of known ulcerative colitis. On admission, she reports 11 bloody bowel movements per day. Her vital signs show a heart rate of 115/min, blood pressure of 110/70 mm Hg, and a temperature of 38.1°C (100.6°F). Laboratory results reveal a hemoglobin of 9.8 g/dL and a C-reactive protein (CRP) of 65 mg/L. The patient is designated as having acute severe ulcerative colitis. Arrange the following steps in the optimal sequential protocol for her diagnostic evaluation, treatment monitoring, and therapeutic escalation.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence for managing and monitoring acute severe ulcerative colitis is: 1) Exclude concurrent superinfections, 2) Initiate intravenous corticosteroids, 3) Evaluate treatment efficacy at day 3 to 5, 4) Initiate medical rescue therapy if refractory, and 5) Monitor rescue therapy response while preparing for potential urgent colectomy.
The protocol for acute severe ulcerative colitis relies heavily on strict temporal monitoring and sequential treatment evaluation to prevent catastrophic complications like toxic megacolon. Management inherently begins with excluding superinfections (e.g., C. difficile or cytomegalovirus) that could mimic a flare or significantly worsen with profound immunosuppression. Once these are excluded, intravenous corticosteroids are initiated. A critical decision point occurs at day 3 to 5 of steroid therapy; objective markers (such as stool frequency and CRP) must be evaluated to determine if the patient is steroid-refractory. If the patient is deemed refractory at this specific milestone, prompt escalation to medical rescue therapy (infliximab or cyclosporine) is indicated. Finally, if the patient fails to improve on rescue therapy over the subsequent 4 to 7 days, surgical intervention (subtotal colectomy) is the definitive next step. Adhering to these rigid monitoring intervals prevents dangerous delays in escalating to life-saving surgical care.

Adım Adım Çözüm

1
Identify the presentation as acute severe ulcerative colitis based on clinical criteria (e.g., >6 bloody stools/day plus systemic toxicity) and order infectious workup including C. difficile toxin and flexible sigmoidoscopy.
Superinfections like cytomegalovirus or C. difficile are effectively ruled out.
High-dose immunosuppressants can be fatal if an active, undiagnosed infection is present.
2
Start intravenous methylprednisolone and monitor objective daily parameters.
The initial inflammatory cascade is suppressed in the majority of patients.
Intravenous corticosteroids represent the standard, rapid-acting first-line therapy for acute severe exacerbations.
3
Re-evaluate the patient's clinical trajectory on days 3 to 5 using strict criteria (e.g., stool frequency and CRP).
The patient is formally categorized as either steroid-responsive or steroid-refractory.
Prolonging ineffective corticosteroids increases surgical morbidity; utilizing a strict timeline prevents the delay of necessary therapeutic escalation.
4
Administer infliximab or cyclosporine for steroid-refractory cases and continue close clinical monitoring.
Second-line medical rescue therapy is attempted to halt disease progression.
These powerful agents can induce remission and avoid surgery in a subset of steroid-refractory patients.
5
Engage surgical consultation for subtotal colectomy if rescue therapy fails after a short 4 to 7 day trial.
Definitive surgical management is prepared and executed if necessary.
Failure of medical rescue therapy carries an imminent high risk of toxic megacolon, perforation, and mortality, necessitating prompt surgical intervention.

Anahtar Kavram

Protocolized step-up management and strict timeline monitoring (e.g., day 3-5 assessment) in acute severe ulcerative colitis.
Soru 1546Soru →

A 71-year-old retired architect visits an ambulatory care center accompanied by her son for a routine follow-up. She was diagnosed with paroxysmal atrial fibrillation three months ago and was prescribed apixaban. During today's visit, she admits she stopped taking the medication a month ago. She states, "I read online that those artificial blood thinners can cause fatal bleeding. I decided to use a natural approach with high-dose Ginkgo biloba and garlic extract instead. I feel perfectly fine, and my son agrees with my choice." Her past medical history includes hypertension and type 2 diabetes mellitus. Her blood pressure is 132/82 mm Hg, and her pulse is 78/min and irregularly irregular. Which of the following is the most appropriate initial step in counseling this patient?

Cevabı ve açıklamayı göster

Cevap: Ask her to share more about the specific sources she read and her understanding of how these natural supplements affect her heart rhythm.

Cevap

The most appropriate initial step is to ask the patient to share more about the sources she read and her understanding of the supplements.
Effective patient counseling and health education, especially when addressing medication non-adherence and medical misinformation, must begin with understanding the patient's underlying beliefs, fears, and health literacy level. By using an open-ended question to explore her reasoning, the physician builds a therapeutic alliance and identifies specific knowledge gaps. Once the patient feels heard and understood, the physician can transition to providing targeted, evidence-based education regarding stroke risk and the true safety profile of prescribed anticoagulants compared to unregulated herbal supplements.

Adım Adım Çözüm

1
Identify the primary clinical challenge.
The patient exhibits medication non-adherence driven by fear of side effects and medical misinformation.
Recognizing the root cause of non-adherence dictates the counseling strategy.
2
Determine the appropriate health education framework.
Employ motivational interviewing and patient-centered communication techniques.
Directly challenging beliefs or citing authoritative mandates usually increases patient resistance.
3
Select the best initial communicative action.
Use open-ended questions to explore the patient's specific knowledge base, fears, and rationale without judgment.
Understanding the patient's exact perspective builds a therapeutic alliance and identifies the specific knowledge gaps that need to be addressed in the education phase.

Anahtar Kavram

In patient counseling, addressing medical misinformation and non-adherence must begin with an open-ended, non-judgmental exploration of the patient's underlying beliefs and fears.
Soru 1547Soru →

A 76-year-old woman is evaluated in the ambulatory care setting for a 1-week history of severe right-sided scalp pain, jaw fatigue when eating, and two episodes of transient visual obscuration in her right eye. Initial laboratory assessment reveals an erythrocyte sedimentation rate (ESR) of 88 mm/h and a C-reactive protein (CRP) level of 45 mg/L. The physician formulates a highly suspicious working diagnosis of giant cell arteritis (GCA).

Arrange the following patient management, monitoring, and therapeutic de-escalation steps in the most appropriate chronological sequence.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct chronological sequence for the management and monitoring of giant cell arteritis is: 1) Initiate high-dose oral prednisone immediately, 2) Obtain a temporal artery biopsy, 3) Document symptom resolution and marker normalization, 4) Begin a gradual prednisone taper, and 5) Maintain a low-dose regimen with long-term relapse monitoring.
The correct sequence strictly follows evidence-based guidelines for managing giant cell arteritis. Because the risk of permanent vision loss is immediate, high-dose prednisone must be the absolute first step. The temporal artery biopsy is the gold standard for diagnosis and is safely obtained within 1 to 2 weeks of starting therapy. Once therapy is initiated, the physician must monitor the patient for 2 to 4 weeks to confirm that symptoms have resolved and acute phase reactants (ESR, CRP) have normalized. Only after this normalization is confirmed can therapeutic de-escalation (a protocolized steroid taper) begin. Finally, patients require a long-term low-dose maintenance regimen with ongoing clinical and laboratory monitoring to prevent and detect relapses.

Adım Adım Çözüm

1
Prioritize immediate organ preservation therapy.
Initiate high-dose systemic glucocorticoids before confirming the diagnosis.
The risk of sudden, irreversible anterior ischemic optic neuropathy outweighs the need for immediate histological confirmation.
2
Sequence the definitive diagnostic procedure.
Schedule and perform the temporal artery biopsy within 1 to 2 weeks of starting therapy.
The biopsy yield remains highly sensitive for up to 14 days after starting steroids, allowing therapy to safely precede diagnosis.
3
Establish the clinical criteria required for therapeutic de-escalation.
Monitor the patient until clinical symptoms resolve and acute phase reactants (ESR/CRP) normalize.
Premature tapering before active inflammation is fully suppressed leads to acute disease flares and treatment failure.
4
Execute the long-term management and surveillance protocol.
Initiate a gradual, multi-month steroid taper followed by a 1 to 2-year maintenance phase with ongoing monitoring.
Giant cell arteritis is a chronic inflammatory condition requiring prolonged immunosuppression and active surveillance to prevent relapse.

Anahtar Kavram

The longitudinal management of giant cell arteritis requires a specific sequence: immediate empirical glucocorticoid therapy to prevent irreversible vision loss, followed by a confirmatory temporal artery biopsy within 1 to 2 weeks. Therapeutic de-escalation (tapering) must only begin after monitoring confirms the normalization of acute phase reactants, eventually transitioning to a multi-year maintenance phase.
Soru 1548Soru →

A 70-year-old man is admitted to the medical intensive care unit with severe septic shock secondary to ischemic bowel. He is endotracheally intubated, hemodynamically unstable, and lacks decision-making capacity. His clinical condition is rapidly deteriorating despite maximal medical therapy. The primary care team determines that a discussion regarding the potential withdrawal of life-sustaining treatment and transition to comfort-focused care is medically indicated. A thorough chart review confirms the patient has no documented advance directive and has not explicitly designated a healthcare proxy. Several individuals have arrived at the intensive care unit, each asserting their right to make medical decisions on the patient's behalf. According to the standard legal hierarchy of surrogate decision-makers in most United States jurisdictions, arrange the following individuals in the correct order of priority to act as the patient's surrogate, from highest priority (first) to lowest priority (last).

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct order of surrogate priority is: 1. Court-appointed legal guardian, 2. Legally married spouse, 3. Adult child, 4. Parent, 5. Adult sibling.
When a patient lacks decision-making capacity and has not legally designated a healthcare proxy (e.g., durable power of attorney for healthcare), medical professionals must turn to a default surrogate decision-maker. In the United States, most states follow a hierarchy similar to the Uniform Health-Care Decisions Act. A court-appointed guardian with healthcare authority always holds the highest priority. If no guardian exists, the legally married spouse is the highest-priority family member. If there is no spouse (or the spouse is unavailable), decision-making falls to adult children. If there are no adult children, parents are next in line, followed finally by adult siblings. Understanding this exact sequence is critical in intensive care and palliative settings to ensure ethical and legally sound goals-of-care discussions.

Adım Adım Çözüm

1
Assess the patient's decision-making capacity and check for advance directives.
The patient lacks capacity and has no advance directive or designated healthcare power of attorney.
A patient with capacity makes their own decisions. If capacity is lost, a designated proxy is consulted first. Without one, the legal default surrogate hierarchy must be utilized.
2
Apply the statutory hierarchy of default surrogate decision-makers.
The legal priority follows the Uniform Health-Care Decisions Act standard: Guardian -> Spouse -> Adult Child -> Parent -> Sibling.
This standardized hierarchy prevents arbitrary decision-making and ensures that the person presumed to be closest to the patient directs their medical care.

Anahtar Kavram

Hierarchy of default surrogate decision-makers
Soru 1549Soru →

A 45-year-old man presents to the primary care clinic for a routine health maintenance examination. He has a history of hypertension and recently elevated liver enzymes. Upon taking a social history, the physician notes that the patient consumes 5 to 6 standard alcoholic beverages daily. Match each of the patient's statements, which represent different stages of readiness to change based on the Transtheoretical Model, with the most appropriate physician counseling strategy.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

"I don't think my drinking is an issue; I function perfectly well at work."
"I've been worrying that alcohol might be affecting my liver, but I can't imagine socializing without it."
"I want to quit completely starting this weekend; I even looked up some local support groups."
"It's been a month since my last drink, and I'm finding new ways to handle stress."

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The correct pairings directly align the patient's stage of change (Precontemplation, Contemplation, Preparation, Action) with the corresponding patient-centered motivational interviewing intervention.
Effective health education and behavioral counseling require tailoring the physician's intervention to the patient's exact stage of readiness. Matching precontemplation with objective feedback without pressure, contemplation with exploring ambivalence, preparation with concrete planning, and action with relapse prevention aligns with established motivational interviewing principles.

Adım Adım Çözüm

1
Analyze each patient statement to determine the current stage of change based on the Transtheoretical Model.
Statement 1 is Precontemplation; Statement 2 is Contemplation; Statement 3 is Preparation; Statement 4 is Action.
Identifying the patient's readiness to change is a prerequisite for selecting the appropriate motivational interviewing strategy.
2
Evaluate the physician counseling strategies to determine which stage they target.
Providing objective feedback targets Precontemplation; exploring ambivalence targets Contemplation; creating a concrete plan targets Preparation; reinforcing coping mechanisms targets Action.
Mismatched strategies (e.g., action-oriented advice for a precontemplative patient) increase resistance and decrease the likelihood of behavioral change.

Anahtar Kavram

Transtheoretical Model of Change and Motivational Interviewing
Soru 1550Soru →

On hospital day 6, a 62-year-old woman admitted to the intensive care unit for a massive pulmonary embolism is evaluated for new-onset right leg swelling and pain. She has been continuously managed with an intravenous unfractionated heparin infusion since admission. Laboratory studies from day 1 showed a platelet count of 240,000/μL240,000/\mu L. Today's routine morning laboratory results reveal a platelet count of 90,000/μL90,000/\mu L and an activated partial thromboplastin time (aPTT) of 45 seconds (institutional therapeutic range: 60-80 seconds). A lower extremity venous duplex ultrasound is performed and demonstrates a new, completely occlusive thrombus in the right femoral vein. Which of the following is the most appropriate next step in the management of this patient's anticoagulation therapy?

Cevabı ve açıklamayı göster

Cevap: Discontinue the unfractionated heparin infusion and initiate intravenous argatroban

Cevap

The correct answer is to discontinue the unfractionated heparin infusion and initiate intravenous argatroban.
The correct management of highly suspected or confirmed Heparin-Induced Thrombocytopenia (HIT) requires the immediate cessation of all heparin products and the initiation of a non-heparin anticoagulant. This patient presents with a classic HIT presentation: a platelet count drop of greater than 50%, occurring 5 to 10 days after heparin initiation, accompanied by a new thrombotic event (a right femoral deep vein thrombosis). Even though her aPTT is subtherapeutic, the new thrombosis is paradoxically driven by HIT antibodies (IgG directed against heparin-platelet factor 4 complexes). These antibodies activate platelets and cause a highly prothrombotic state. Direct thrombin inhibitors, such as argatroban or bivalirudin, are the drugs of choice for anticoagulation in this setting to prevent further thrombosis while allowing platelet counts to recover.

Adım Adım Çözüm

1
Evaluate the patient's new-onset symptoms and laboratory changes in the context of her current pharmacotherapy.
The patient experienced a greater than 50% drop in platelets (from 240,000/μL240,000/\mu L to 90,000/μL90,000/\mu L) and developed a new thrombosis (femoral DVT) on day 6 of intravenous heparin therapy.
Monitoring for adverse effects of high-risk medications is a critical component of treatment evaluation.
2
Calculate the clinical probability for Heparin-Induced Thrombocytopenia (HIT) using the 4T score.
The patient scores highly: Thrombocytopenia >50%, Timing is 5-10 days, Thrombosis is present, and there is no obvious oTher cause.
A high 4T score necessitates immediate clinical intervention prior to the return of confirmatory laboratory testing (e.g., serotonin release assay).
3
Determine the appropriate treatment modification to halt the adverse reaction and manage the underlying condition.
Discontinue all heparin exposure immediately and begin a direct thrombin inhibitor (such as argatroban or bivalirudin) or a factor Xa inhibitor.
Continued heparin exposure fuels the antibody-mediated platelet activation, leading to severe, life-threatening hypercoagulability.

Anahtar Kavram

Heparin-Induced Thrombocytopenia (HIT) Diagnosis and Management
Tahmini Süre:1m 30s
Soru 1551Soru →

Match each patient statement regarding lifestyle modification (representing a specific stage in the Transtheoretical Model of Change) to the most appropriate initial physician counseling strategy.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 45-year-old man with type 2 diabetes says, 'My grandfather had diabetes and lived to 90 eating whatever he wanted. I am not going to change my diet.'
A 32-year-old woman with obesity states, 'I know I need to lose weight for my joint pain, but with my current work schedule, I just do not have the time to cook or exercise.'
A 55-year-old man who smokes says, 'I have set my quit date for next Monday and threw away all my ashtrays this morning.'
A 28-year-old man with alcohol use disorder states, 'I have not touched a drink for a month, but passing my favorite bar on the way home is very tempting.'

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

Precontemplation matches with avoiding arguments and providing objective feedback with permission. Contemplation matches with exploring ambivalence and pros/cons. Preparation matches with establishing a concrete plan and anticipating early hurdles. Action matches with reinforcing success and developing relapse avoidance strategies.
Effective health counseling relies on the Transtheoretical Model of Change. For precontemplation, the goal is to introduce doubt safely. For contemplation, the goal is to resolve ambivalence. For preparation, the goal is to finalize an action plan. For action, the goal is to prevent relapse by managing specific triggers.

Adım Adım Çözüm

1
Analyze each patient statement to determine their current stage of readiness in the Transtheoretical Model of Change.
Patient 1 is in Precontemplation. Patient 2 is in Contemplation. Patient 3 is in Preparation. Patient 4 is in Action.
Accurate identification of the patient's readiness stage dictates the most effective counseling intervention.
2
Select the physician counseling strategy that appropriately targets the identified stage of change.
Precontemplation requires raising doubt without confrontation. Contemplation requires resolving ambivalence. Preparation requires action planning. Action requires relapse prevention.
Mismatched counseling strategies (e.g., action planning for a patient in precontemplation) often lead to physician frustration and patient resistance.

Anahtar Kavram

Matching physician counseling strategies to the patient's specific stage in the Transtheoretical Model of Change significantly improves the efficacy of health education and behavioral modification.
Soru 1552Soru →

An asymptomatic 6969-year-old male visits his primary care physician for a scheduled health maintenance examination. His medical history includes only mild osteoarthritis of the knees. The patient states that he smoked one pack of cigarettes daily starting at age 1818 but successfully quit on his 4545 th birthday. His blood pressure is 122/78122/78 mm Hg, heart rate is 7272/min, and body mass index is 2424 kg/m 2^2. Cardiopulmonary and abdominal examinations reveal no abnormalities. Based on current guidelines, which of the following is the most appropriate screening intervention for this patient?

Cevabı ve açıklamayı göster

Cevap: Ultrasonography of the abdomen

Cevap

Ultrasonography of the abdomen
The correct answer is ultrasonography of the abdomen. The United States Preventive Services Task Force recommends a one-time screening for an abdominal aortic aneurysm with ultrasonography in men aged 6565 to 7575 years who have ever smoked (defined as 100100 or more cigarettes in a lifetime). This patient is a 6969-year-old male with a significant smoking history, making this the most appropriate next step in his preventive care.

Adım Adım Çözüm

1
Evaluate patient demographics and risk factors.
The patient is a 6969-year-old male with a 2727 pack-year smoking history who quit 2424 years ago.
Age, sex, and smoking history determine eligibility for specific age- and risk-based screening programs.
2
Assess the indication for abdominal aortic aneurysm (AAA) screening.
The patient meets the criteria for a one-time AAA screening.
Guidelines recommend a one-time screening for men aged 6565 to 7575 years who have ever smoked.
3
Select the appropriate imaging modality for AAA screening.
Ultrasonography of the abdomen is the standard screening modality.
It is highly sensitive, non-invasive, and does not expose the asymptomatic patient to radiation.
4
Rule out lung cancer screening.
The patient does not qualify for annual low-dose computed tomography.
Although he has a >20>20 pack-year smoking history, he quit more than 1515 years ago.

Anahtar Kavram

Abdominal aortic aneurysm screening guidelines
Soru 1553Soru →

A 68-year-old man is evaluated for care transition on hospital day 24. He was initially admitted to the intensive care unit (ICU) for severe acute pancreatitis complicated by acute respiratory distress syndrome and acute kidney injury. His hospital course was prolonged, requiring vasopressor support for 12 days and initiation of intermittent hemodialysis.

Current status:
- He has been hemodynamically stable without vasopressors for 10 days.
- A tracheostomy was performed on hospital day 14. He remains on mechanical ventilation on pressure support mode but is actively being weaned.
- Nutrition is provided via a percutaneous endoscopic gastrostomy (PEG) tube.
- He continues to require hemodialysis three days a week.
- Neurologically, he is alert, follows complex commands, and communicates by using a letter board.
- He has profound ICU-acquired weakness. He requires maximal assistance for all bed mobility and fatigues after 15 minutes of sitting on the edge of the bed with physical therapy.

The critical care team determines he no longer requires ICU-level monitoring. Which of the following is the most appropriate care setting for this patient's disposition?

Cevabı ve açıklamayı göster

Cevap: Long-term acute care hospital

Cevap

The correct disposition is a long-term acute care hospital (LTACH).
The correct disposition is a long-term acute care hospital. This patient is medically stable enough to leave the intensive care unit but has complex, high-acuity medical needs that exceed the capabilities of lower-level facilities. The classic indications for LTACH admission include the need for prolonged mechanical ventilation weaning, complex wound care, and multi-organ failure management (such as concurrent ventilator weaning and hemodialysis). Because he is actively weaning from the ventilator and requires hemodialysis, an LTACH provides the specialized respiratory therapy and critical care nursing required for his ongoing recovery.

Adım Adım Çözüm

1
Evaluate the patient's medical acuity and ongoing clinical needs.
The patient is hemodynamically stable but requires active mechanical ventilation weaning and hemodialysis.
Determining medical acuity differentiates between the need for continued acute hospital care, long-term acute care, or lower-level skilled nursing.
2
Assess the patient's functional status and ability to participate in rehabilitation.
The patient has profound ICU-acquired weakness and fatigues after only 15 minutes of therapy.
Functional tolerance dictates eligibility for acute inpatient rehabilitation versus other post-acute care settings.
3
Match the clinical and functional profile to the appropriate post-acute care setting criteria.
The patient needs complex medical care (LTACH) rather than intensive rehabilitation (IRF) or basic skilled nursing (SNF).
LTACHs are specifically designed for stable patients with severe, prolonged critical illness requiring multi-organ support and prolonged ventilator weaning.

Anahtar Kavram

Criteria for Long-Term Acute Care Hospital (LTACH) versus Inpatient Rehabilitation Facility (IRF) admission
Tahmini Süre:2m 0s
Soru 1554Soru →

A 60-year-old woman is evaluated in the intensive care unit on day 10 of her hospitalization. She was initially admitted for an acute submassive pulmonary embolism and started on a continuous intravenous unfractionated heparin infusion. On hospital day 6, her platelet count dropped abruptly from a baseline of 240,000/mm³ to 70,000/mm³. Heparin-induced thrombocytopenia (HIT) was suspected; heparin was immediately discontinued, and a continuous intravenous infusion of argatroban was initiated. Subsequent enzyme-linked immunosorbent assay (ELISA) and serotonin release assay (SRA) confirmed the diagnosis of HIT.

Laboratory results over the last few days are as follows:

Hospital DayPlatelet CountaPTT (sec)
Day 670,000/mm³45
Day 8110,000/mm³65
Day 10165,000/mm³68

The patient is clinically stable with no signs of active bleeding or recurrent thrombosis. The care team plans to transition her to oral warfarin for long-term anticoagulation. Which of the following is the most appropriate protocol for monitoring and evaluating this patient's transition to oral warfarin therapy?

Cevabı ve açıklamayı göster

Cevap: Initiate warfarin concurrently, discontinue argatroban when the combined INR exceeds 4.0, and recheck the INR in 4 to 6 hours.

Cevap

Initiate warfarin concurrently, discontinue argatroban when the combined INR exceeds 4.0, and recheck the INR in 4 to 6 hours.
The correct answer identifies the standard, guideline-based protocol for bridging argatroban to warfarin. Argatroban is a direct thrombin inhibitor that interferes with the prothrombin time (PT) assay, artificially elevating the INR. Therefore, when both drugs are co-administered, a target INR of 2.0 to 3.0 is inadequate because it reflects the combined effect, not the warfarin effect alone. Guidelines recommend co-administering both drugs until the combined INR is > 4.0. At that point, argatroban is held, and because it has a short half-life (~45 minutes in patients with normal hepatic function), rechecking the INR in 4 to 6 hours provides an accurate measurement of the true, warfarin-induced INR. If this repeat INR is in the therapeutic range (2.0 to 3.0), argatroban can be permanently discontinued.

Adım Adım Çözüm

1
Evaluate the patient's readiness to transition to warfarin.
The patient's platelet count has recovered to >150,000/mm³ (currently 165,000/mm³), which is the standard threshold for safely initiating warfarin in a patient with HIT.
Starting warfarin before platelet recovery in HIT can increase the risk of venous limb gangrene and microthrombosis.
2
Analyze the pharmacokinetic interaction between argatroban and the INR laboratory assay.
Argatroban is a direct thrombin inhibitor that artificially prolongs the prothrombin time (PT), leading to a falsely elevated INR.
Understanding this lab interference is critical to prevent premature discontinuation of the parenteral anticoagulant.
3
Select the correct bridging protocol based on established guidelines for argatroban-to-warfarin transition.
The protocol requires co-administering both drugs until the combined, artificially elevated INR is >4.0.
An INR of 2.0 to 3.0 on combined therapy would reflect a subtherapeutic true warfarin level.
4
Determine the appropriate follow-up monitoring step after stopping argatroban.
Stop the argatroban infusion and recheck the INR in 4 to 6 hours.
Argatroban has a short half-life (~45 minutes). Rechecking the INR after 4-6 hours allows the drug to clear, revealing the accurate, true INR produced solely by warfarin, which should be in the target 2.0-3.0 range.

Anahtar Kavram

Patients transitioning from argatroban to warfarin must have overlapping therapy until the combined INR is >4.0 due to argatroban's artificial elevation of the prothrombin time; the true INR must be verified 4-6 hours after stopping argatroban.
Tahmini Süre:2m 0s
Soru 1555Soru →

A 4141-year-old woman is evaluated in the rheumatology clinic for follow-up of newly diagnosed rheumatoid arthritis. Two weeks ago, she was started on oral methotrexate and daily folic acid supplementation. She reports mild nausea but otherwise feels well. Physical examination shows mild swelling in the metacarpophalangeal joints of both hands, which is improved from her previous visit. As part of her ongoing maintenance therapy, which of the following routine evaluations are necessary to monitor for potential adverse effects of her primary disease-modifying medication? (Select all that apply)

Geçerli olan tümünü seçin

Cevabı ve açıklamayı göster

Cevap: Complete blood count; Hepatic aminotransferases

Cevap

The correct evaluations for routine monitoring of methotrexate therapy are a complete blood count and hepatic aminotransferases.
Methotrexate is a folate antimetabolite commonly used as a first-line conventional synthetic disease-modifying antirheumatic drug (DMARD). Its most significant dose-dependent adverse effects include bone marrow suppression (leading to leukopenia, anemia, or thrombocytopenia) and hepatotoxicity. Therefore, clinical guidelines mandate routine serial monitoring with a complete blood count, hepatic aminotransferases, and serum creatinine (as the drug is renally cleared and renal dysfunction increases the risk of toxicity).

Adım Adım Çözüm

1
Identify the primary medication being used for treatment.
The patient is taking methotrexate for rheumatoid arthritis.
Different disease-modifying antirheumatic drugs (DMARDs) have specific adverse effect profiles dictating unique monitoring protocols.
2
Determine the common and severe adverse effects associated with methotrexate.
Methotrexate can cause dose-dependent bone marrow suppression, hepatotoxicity, and renal impairment.
Understanding the toxicity profile directly informs which physiological systems require regular surveillance.
3
Select the appropriate routine monitoring tests based on the toxicity profile.
A complete blood count (CBC) and hepatic aminotransferases (LFTs) are required.
Routine serial monitoring of CBC, LFTs, and renal function is the standard of care to detect asymptomatic myelosuppression and hepatotoxicity in patients taking methotrexate.

Anahtar Kavram

Routine monitoring for patients on maintenance methotrexate therapy includes regular assessment of complete blood count, hepatic aminotransferases, and serum creatinine to detect bone marrow suppression, hepatotoxicity, and renal impairment.
Soru 1556Soru →

A 54-year-old woman is evaluated in the oncology clinic at 4:00 PM for a fever. She has a history of estrogen receptor-positive breast cancer and received her second cycle of adjuvant docetaxel and cyclophosphamide 8 days ago. She reports mild fatigue and chills but denies cough, shortness of breath, abdominal pain, diarrhea, or dysuria. She lives entirely alone on a rural farm approximately 90 miles (145 km) from the nearest hospital or urgent care facility. She drove herself to the clinic today because she happened to be in town for errands. Her temperature is 38.6∘C38.6^\circ\text{C} (101.5∘F101.5^\circ\text{F}), blood pressure is 118/76 mm Hg, pulse is 88/min, and respirations are 16/min. Physical examination, including inspection of the central venous port site, shows no abnormalities. Laboratory studies show:

Leukocyte count: 800/mm3800/\text{mm}^3
Neutrophils: 10%10\%
Hemoglobin: 11.2 g/dL
Platelets: 125,000/mm3125,000/\text{mm}^3
Creatinine: 0.8 mg/dL
Total bilirubin: 0.7 mg/dL

Based on objective risk stratification and the patient's current status, which of the following is the most appropriate disposition and care transition for this patient?

Cevabı ve açıklamayı göster

Cevap: Admission to the general medical ward for empiric intravenous antibiotic therapy

Cevap

Admission to the general medical ward for empiric intravenous antibiotic therapy
The most appropriate disposition is admission to the general medical ward. While this patient's clinical presentation and objective risk scores (such as the MASCC Risk Index) categorize her as 'low risk' for medical complications, outpatient management of febrile neutropenia has strict logistical prerequisites. Guidelines dictate that eligible patients must have a 24/7 caregiver, a telephone, reliable transportation, and live within a 1-hour drive (or approximately 30 miles) of a medical facility. Because this patient lives alone and is 90 miles away, she fails the psychosocial and logistical criteria for safe outpatient care. She requires inpatient admission to a regular medical floor for empiric intravenous antibiotics and close monitoring.

Adım Adım Çözüm

1
Calculate the Absolute Neutrophil Count (ANC).
The total WBC is 800/mm3800/\text{mm}^3 and neutrophils are 10%10\%. The ANC is 800×0.10=80/mm3800 \times 0.10 = 80/\text{mm}^3.
An ANC <500/mm3< 500/\text{mm}^3 combined with a single oral temperature ≥38.3∘C\geq 38.3^\circ\text{C} defines neutropenic fever, an oncologic emergency requiring immediate risk stratification.
2
Determine the patient's objective medical risk using a standardized scoring system like the MASCC Risk Index.
The patient has mild symptoms, normal blood pressure, solid tumor, outpatient onset, and age <60< 60, resulting in a high MASCC score (≥21\geq 21).
A high MASCC score indicates a low risk for severe medical complications, suggesting she might be clinically eligible for outpatient oral antibiotic therapy.
3
Evaluate the patient's social determinants, functional capacity, and logistical barriers against the mandatory criteria for outpatient care transitions.
The patient lives entirely alone and resides 90 miles (approximately 1.5 to 2 hours) from the nearest hospital.
Standard oncologic guidelines mandate that patients treated for febrile neutropenia in the outpatient setting MUST have a caregiver present 24/7, possess a telephone and transportation, and live within 1 hour (or ≤30\leq 30 miles) of a medical center.
4
Synthesize the objective severity score with the logistical constraints to finalize the disposition.
Because she fails the logistical requirements for safe discharge, outpatient management is contraindicated.
She must be admitted to the general medical ward for initial empiric therapy and observation to ensure immediate response capability in the event of rapid clinical deterioration.

Anahtar Kavram

Disposition of a patient with febrile neutropenia requires synthesizing objective clinical severity scores (e.g., MASCC or CISNE) with absolute logistical requirements (proximity to a hospital, 24/7 caregiver presence) to ensure safe care setting transitions.
Soru 1557Soru →

A 38-year-old man is admitted to the hospital with a 1-week history of severe fatigue, easy bruising, and gingival bleeding. Laboratory evaluation reveals a leukocyte count of 3,500/mm33,500/\text{mm}^3, hemoglobin of 8.2 g/dL8.2\text{ g/dL}, and platelet count of 22,000/mm322,000/\text{mm}^3. Coagulation studies demonstrate a prothrombin time of 18 seconds, activated partial thromboplastin time of 45 seconds, and a fibrinogen level of 90 mg/dL90\text{ mg/dL}. Bone marrow aspiration and cytogenetics confirm the presence of a t(15;17)t(15;17) translocation. The patient is diagnosed with low-risk acute promyelocytic leukemia and is scheduled to begin induction therapy with all-trans retinoic acid and arsenic trioxide. A baseline electrocardiogram shows a QTc interval of 415 ms415\text{ ms}. Which of the following are REQUIRED components of the monitoring and treatment evaluation protocol for this patient's new pharmacotherapy? (Select all that apply)

Geçerli olan tümünü seçin

Cevabı ve açıklamayı göster

Cevap: Monitor daily weight, oxygen saturation, and chest radiographs to evaluate for differentiation syndrome; Perform serial electrocardiograms and maintain serum potassium above 4.0 mEq/L4.0\text{ mEq/L} and magnesium above 2.0 mEq/L2.0\text{ mEq/L}

Cevap

The correct required components are monitoring daily weight, oxygen saturation, and chest radiographs to evaluate for differentiation syndrome, alongside performing serial electrocardiograms and maintaining strict electrolyte parameters (potassium > 4.0 mEq/L, magnesium > 2.0 mEq/L).
Induction therapy for low-risk acute promyelocytic leukemia with all-trans retinoic acid (ATRA) and arsenic trioxide (ATO) is associated with two life-threatening, drug-specific toxicities that require strict monitoring protocols. First, ATRA induces rapid terminal differentiation of malignant promyelocytes, which can trigger differentiation syndrome. This condition is characterized by capillary leak, pulmonary infiltrates, weight gain, and hypoxia; therefore, monitoring daily weight, respiratory parameters, and chest radiographs is critical. Second, ATO significantly prolongs the QTc interval, predisposing patients to Torsades de Pointes. Standard clinical guidelines mandate serial electrocardiograms during induction and the strict maintenance of serum potassium above 4.0 mEq/L4.0\text{ mEq/L} and magnesium above 2.0 mEq/L2.0\text{ mEq/L} to minimize arrhythmic risk.

Adım Adım Çözüm

1
Analyze the clinical scenario
The patient has low-risk acute promyelocytic leukemia (APL) and is starting an anthracycline-free induction regimen with all-trans retinoic acid (ATRA) and arsenic trioxide (ATO).
Identifying the specific pharmacological agents is required to anticipate their unique toxicities.
2
Identify the toxicity profile and monitoring requirements of ATRA
ATRA induces rapid differentiation of malignant promyelocytes, which can trigger a systemic inflammatory response known as differentiation syndrome. This necessitates strict clinical monitoring of respiratory status, fluid balance, and chest imaging.
Differentiation syndrome is a potentially fatal complication presenting with capillary leak, pulmonary infiltrates, and weight gain.
3
Identify the toxicity profile and monitoring requirements of ATO
ATO significantly prolongs the QTc interval. The standard protocol mandates serial electrocardiograms and strict maintenance of serum potassium (> 4.0 mEq/L) and magnesium (> 2.0 mEq/L).
QTc prolongation predisposes the patient to life-threatening ventricular arrhythmias, specifically Torsades de Pointes.
4
Evaluate and rule out the incorrect monitoring or treatment strategies
Recognize that APL coagulopathy is driven by hyperfibrinolysis (contraindicating heparin), that ATRA-induced leukocytosis is an expected effect managed with cytoreduction (not discontinuation), and that ATRA/ATO regimens lack the cumulative cardiotoxicity of anthracyclines (making routine serial echocardiography unnecessary).
Distinguishing appropriate disease-specific and drug-specific management from general oncology protocols prevents iatrogenic harm.

Anahtar Kavram

Monitoring and Treatment Evaluation of Acute Promyelocytic Leukemia (APL) Induction Therapy
Soru 1558Soru →

A 54-year-old woman is admitted to an inpatient hospice facility for the management of intractable symptoms secondary to terminal metastatic cervical cancer. Her clinical course is complicated by a malignant bowel obstruction, rendering her completely intolerant to enteral intake. Over the past 48 hours, she has experienced relentless nausea, frequent large-volume emesis, and diffuse abdominal pain. These symptoms have persisted despite maximally tolerated continuous intravenous infusions of hydromorphone, haloperidol, and octreotide, as well as scheduled intravenous dexamethasone. On examination, the patient is cachectic, visibly distressed, crying, and writhing in bed. Her estimated prognosis is hours to a few days. During the bedside evaluation, the patient clearly states, "I cannot take this agony anymore. Please just put me to sleep so I do not have to suffer until the end." The physician assesses that the patient fully understands her condition and the consequences of her request. Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Initiate a continuous intravenous infusion of midazolam

Cevap

The most appropriate next step is to initiate a continuous intravenous infusion of midazolam to provide proportionate palliative sedation.
The correct action addresses the patient's refractory suffering through proportionate palliative sedation. When a patient nearing the end of life (prognosis of days to weeks) experiences intractable symptoms that cannot be controlled with aggressive symptom-directed therapies, it is ethically and medically appropriate to reduce their level of consciousness to relieve suffering. This relies on the ethical principle of double effect. Midazolam, a short-acting benzodiazepine, is the first-line agent for this purpose because it reliably provides sedation and amnesia.

Adım Adım Çözüm

1
Evaluate the patient's symptom burden and prognosis.
The patient has refractory pain and vomiting from a malignant bowel obstruction despite maximal medical therapy, with a prognosis of hours to days.
Establishing the presence of refractory terminal symptoms and a short prognosis is required to consider palliative sedation.
2
Assess the patient's decision-making capacity and request.
The patient clearly understands her condition and requests to be "put to sleep" to escape suffering.
Informed consent from a capacitated patient (or their surrogate) is necessary to initiate sedation.
3
Select the appropriate pharmacologic agent for palliative sedation.
A sedative-hypnotic agent, typically a benzodiazepine like midazolam, is selected.
Midazolam reliably induces sedation and amnesia, fulfilling the ethical principle of double effect to relieve intractable suffering at the end of life.

Anahtar Kavram

Proportionate palliative sedation using sedative-hypnotics is indicated for patients with refractory symptoms and a prognosis of less than two weeks, provided there is informed consent.
Tahmini Süre:1m 30s
Soru 1559Soru →

A 55-year-old patient with newly diagnosed chronic obstructive pulmonary disease is seen in the primary care clinic. She continues to smoke one pack of cigarettes daily. When the topic of smoking cessation is raised, she states, "I know smoking is worsening my lungs, but my job as a project manager is incredibly stressful right now, and cigarettes are the only way I can cope." The physician plans to utilize the core principles of Motivational Interviewing to address her tobacco use. Arrange the following physician responses in the correct chronological sequence to appropriately execute the four fundamental processes of Motivational Interviewing.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequential order aligns with the four processes of Motivational Interviewing: Engaging, Focusing, Evoking, and then Planning.
The correct sequence strictly follows the Motivational Interviewing (MI) framework. Communication must begin with Engaging to build a strong alliance using empathy and reflective listening. Next, Focusing allows the physician and patient to agree on the target behavior (agenda setting). Once the target is clear, Evoking is used to draw out the patient's intrinsic motivation and 'change talk'. Only after ambivalence is resolved and readiness is confirmed does the interaction move to Planning, where concrete action steps are collaboratively designed.

Adım Adım Çözüm

1
Identify the underlying counseling framework required by the clinical scenario.
The physician is explicitly utilizing Motivational Interviewing, which relies on four sequential phases: Engaging, Focusing, Evoking, and Planning.
Recognizing the theoretical framework is essential to correctly sequence the communication steps without generating patient resistance.
2
Identify the statement representing the 'Engaging' process.
The statement reflecting on the patient's immense pressure at work and use of smoking as a coping tool.
Establishing trust and rapport through reflective listening is the mandatory first step before any behavioral intervention can begin.
3
Identify the statement representing the 'Focusing' process.
The statement asking what the patient would prefer to concentrate on during the discussion.
A shared agenda and clear direction must be established collaboratively before attempting to elicit motivation for a specific change.
4
Identify the statement representing the 'Evoking' process.
The statement asking for other personal reasons the patient might consider quitting.
The physician must encourage the patient to vocalize their own internal reasons for change (change talk) to overcome ambivalence.
5
Identify the statement representing the 'Planning' process.
The statement outlining exactly how and when to use nicotine replacement therapies.
Concrete action steps and bridging to treatment should only be formulated once motivation is secured and the patient is ready to change.

Anahtar Kavram

Motivational Interviewing follows four fundamental, sequential processes: Engaging (building rapport), Focusing (establishing an agenda), Evoking (eliciting change talk), and Planning (developing an action strategy).
Soru 1560Soru →

During a scheduled wellness evaluation, a 68-year-old woman is seen in the outpatient clinic. She reports feeling well and has no new symptomatic complaints. Her active medical problems include essential hypertension and osteoarthritis, both of which are well-controlled. Her surgical history is notable for a total abdominal hysterectomy with bilateral salpingo-oophorectomy performed at age 65 for symptomatic uterine leiomyomas. Several years prior to that procedure, at age 57, she underwent a loop electrosurgical excision procedure for cervical intraepithelial neoplasia 3 (CIN 3) with clear margins. Subsequent follow-up testing prior to her hysterectomy was negative.

She has a 30-pack-year smoking history but successfully quit 18 years ago. She consumes alcohol rarely and exercises three times weekly. Recent preventive care includes a normal screening mammogram 6 months ago, a normal screening colonoscopy at age 62, and a normal dual-energy x-ray absorptiometry scan at age 65. Her immunizations, including recombinant zoster, pneumococcal, and seasonal influenza vaccines, are up to date. Vital signs today are within normal limits.

Which of the following screening recommendations is most appropriate for this patient at this visit?

Cevabı ve açıklamayı göster

Cevap: Cytologic evaluation of the vaginal cuff

Cevap

Cytologic evaluation of the vaginal cuff
This patient had a high-grade precancerous cervical lesion (CIN 3) treated at age 57. Current guidelines mandate that individuals with a history of CIN 2, CIN 3, or cervical cancer continue screening for 25 years following appropriate management. Although she underwent a total abdominal hysterectomy at age 65 for benign fibroids, her history of CIN 3 requires continued screening of the vaginal cuff (via cytology or human papillomavirus testing) until 25 years have passed since her treatment (i.e., until age 82 for this patient).

Adım Adım Çözüm

1
Analyze the patient's gynecologic and surgical history.
The patient had a total hysterectomy (removal of uterus and cervix) at age 65, but has a history of high-grade cervical dysplasia (CIN 3) treated at age 57.
Prior history of dysplasia dictates the rules for discontinuing or maintaining lower genital tract screening.
2
Apply evidence-based screening guidelines for cervical cancer prevention.
Guidelines require 25 years of continued screening after treatment of CIN 2 or CIN 3. Because she lacks a cervix, this is accomplished via vaginal cuff screening.
This requirement persists even if the patient surpasses the standard cessation age of 65 or undergoes a hysterectomy.
3
Evaluate the patient's other risk factors against current preventive guidelines.
Her smoking cessation was >15 years ago (excluding her from LDCT), she is female (excluding AAA screening), and her prior DEXA was recent and normal (excluding repeat imaging).
Systematically eliminates alternative screening modalities that might otherwise act as strong distractors.

Anahtar Kavram

Patients with a history of CIN 2, CIN 3, or cervical cancer must continue routine lower genital tract screening for 25 years following appropriate management, even if they have surpassed age 65 or have undergone a total hysterectomy.
ÖncekiSayfa 78 / 104Sonraki
Patient Management Alıştırma Soruları — USMLE Step 3 — Sayfa 78 | Examkin